Stockreport

Baudax Bio Announces Proposed Public Offering of Common Stock and Warrants

Baudax Bio, Inc.  (BXRX) 
PDF MALVERN, Pa., March 23, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (“Baudax” or the “Company”) (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acut [Read more]